Table 1.
Major Clinical and Laboratory Characteristics of CLL Patients
| No | Age (year) | Sex | WBC × 103/mm3 | Lym (%) | Hb (g/dL) | HCT | PLT × 103/mm3 | Rai stage | Organomegaly |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 58 | M | 24,400 | 53.0 | 14.7 | 41.8 | 191,000 | 0 | None |
| 2 | 58 | M | 31,000 | 83.0 | 11.4 | 36.5 | 196,000 | I | None |
| 3 | 65 | F | 24,000 | 81.0 | 13.8 | 43.6 | 211,000 | 0 | None |
| 4 | 60 | M | 8,900 | 48.7 | 14.3 | 43.6 | 158,000 | 0 | None |
| 5 | 54 | M | 119,500 | 29.0 | 11.5 | 36.6 | 183,000 | II | SPM |
| 6 | 64 | F | 47,000 | 85.0 | 13.7 | 41.0 | 213,000 | 0 | None |
| 7 | 61 | M | 37,600 | 76.9 | 15.5 | 45.0 | 183,000 | I | LAP |
| 8 | 65 | M | 39,100 | 84.0 | 11.4 | 34.6 | 128,000 | I | None |
| 9 | 65 | M | 21,600 | 77.5 | 14.0 | 42.7 | 139,000 | 0 | None |
| 10 | 87 | M | 12,400 | 56.4 | 9.7 | 31.3 | 145,000 | 0 | None |
| 11 | 85 | F | 62,800 | 87.9 | 11.8 | 37.9 | 268,000 | II | SPM |
CLL, chronic lymphocytic leukemia; M, Male; F, Female; LAP, lymphadenopathy; SPM, splenomegaly; HPM, hepatomegaly; WBC, white blood cell count; Lym, lymphocytes percent in peripheral blood; PLT, platelet count; Hb, hemoglobin.